Imaging Markers of Progression in Parkinson's Disease

BACKGROUND: Parkinson's disease (PD) is the second‐most common neurodegenerative disorder after Alzheimer's disease; however, to date, there is no approved treatment that stops or slows down disease progression. Over the past decades, neuroimaging studies, including molecular imaging and M...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mov Disord Clin Pract
Glavni autori: Strafella, Antonio P., Bohnen, Nico I., Pavese, Nicola, Vaillancourt, David E., van Eimeren, Thilo, Politis, Marios, Tessitore, Alessandro, Ghadery, Christine, Lewis, Simon
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Reviews
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6277366/
https://ncbi.nlm.nih.gov/pubmed/30637278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.12673
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items